Worcester Foundation for Experimental Biology Shrewsbury, Massachusetts 01545
The metabolism of estrone sulfate has been studied in normal,young males by single injections of 6,7-3H-estrone sulfate (9subjects); by constant infusions of 6,7-3H-estrone sulfate (8subjects), 6,7-3H-estrone (5 subjects), and 6,7-3H-estradiol(5 subjects); and by the measurement of the concentration ofradioactivity in plasma as estrone sulfate, estrone, and estradiol.
The disappearance of radioactivity as estrone sulfate followingthe single injections of 6,7-3H-estrone sulfate can be describedas a function which is the sum of two exponentials. The initialrapid component (T = 3 min) represents spread into and transferfrom a space, with a volume of 7.2 rh 0.6 (SE) L. The mean valuefor the rate constant of total removal (reversible and irreversible)from this space is 266 ± 2 7 (SE) units/day of which11.1 ± 2.4 (SE) % is irreversible. The mean metabolicclearance rate (MCR R) is 105 ± 20 (SE) L/day/m2
Using the constant infusion technique the mean MCRr is 80 ±10 (SE) L/day/m2. The overall mean MCR of estrone sulfate is90 ± 10 (SE) L/day/m2.
The mean transfer constant or fraction of 3H-estrone sulfate infused which is measuredas estrone in the blood is 0.15 with 95% confidence limits of0.12 to 0.18. In the two subjects in whom 3H-estradiol was measuredthe was 0.022 and 0.044.
For the infusion of 3H-estrone and 3H-estradiol the mean and (95% confidence limits) were 0.40 (0.21 to 0.81) and 0.42 (0.30to 0.58).
Using the available data for and []BB values, it is probable that most of the estronesulfate entering the blood each day does so as a result of conversionfrom the free estrogens and little, if any, arises as a resultof direct secretion.
This work was supported by USPHS Grant AM-11252.
A portion of this work was presented at the 53rd Meeting ofthe Endocrine Society, San Francisco, Calif., 1971.
Received July 20, 1971.
This article has been cited by other articles:
S. L. Hui, A. J. Perkins, L. Zhou, C. Longcope, M. J. Econs, M. Peacock, C. McClintock, and C. C. Johnston Jr. Bone Loss at the Femoral Neck in Premenopausal White Women: Effects of Weight Change and Sex-Hormone Levels
J. Clin. Endocrinol. Metab.,
April 1, 2002;
87(4):
1539 - 1543.
[Abstract][Full Text][PDF]
B. R. Bhavnani, A. Cecutti, and A. Gerulath Pharmacokinetics of 17{beta}-Dihydroequilin Sulfate in Normal Postmenopausal Women Under Steady State Conditions
Reproductive Sciences,
March 1, 2002;
9(2):
102 - 110.
[Abstract][PDF]
B. R. Bhavnani, J. A. Nisker, J. Martin, F. Aletebi, L. Watson, and J. K. Milne Comparison of Pharmacokinetics of a Conjugated Equine Estrogen Preparation (Premarin) and a Synthetic Mixture of Estrogens (C.E.S.) in Postmenopausal Women
Reproductive Sciences,
May 1, 2000;
7(3):
175 - 183.
[Abstract][PDF]
B. Gladue, R Green, and R. Hellman Neuroendocrine response to estrogen and sexual orientation
Science,
September 28, 1984;
225(4669):
1496 - 1499.
[Abstract][PDF]